{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T00:06:35Z","timestamp":1793318795038,"version":"4.5.0"},"reference-count":105,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T00:00:00Z","timestamp":1795132800000},"content-version":"am","delay-in-days":384,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008460","name":"National Center for Complementary and Integrative Health","doi-asserted-by":"publisher","award":["R01AT010779"],"award-info":[{"award-number":["R01AT010779"]}],"id":[{"id":"10.13039\/100008460","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Chemical Biology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.chembiol.2025.10.005","type":"journal-article","created":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T05:34:46Z","timestamp":1762580086000},"page":"1412-1428.e5","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Rapid suppression of neuropathic pain and somatosensory hyperactivity by nano-formulated cannabidiol"],"prefix":"10.1016","volume":"32","author":[{"given":"Jingyu","family":"Feng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Page","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leeyup","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhigang","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2249-5417","authenticated-orcid":false,"given":"Kuan Hong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.chembiol.2025.10.005_bib1","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/nrn3811","article-title":"Early phytocannabinoid chemistry to endocannabinoids and beyond","volume":"15","author":"Mechoulam","year":"2014","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.chembiol.2025.10.005_bib2","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.neuron.2022.12.022","article-title":"THC and CBD: Similarities and differences between siblings","volume":"111","author":"Stella","year":"2023","journal-title":"Neuron"},{"key":"10.1016\/j.chembiol.2025.10.005_bib3","doi-asserted-by":"crossref","first-page":"S117","DOI":"10.1097\/j.pain.0000000000002266","article-title":"International Association for the Study of Pain Presidential Task Force on Cannabis and Cannabinoid Analgesia: research agenda on the use of cannabinoids, cannabis, and cannabis-based medicines for pain management","volume":"162","author":"Haroutounian","year":"2021","journal-title":"Pain"},{"key":"10.1016\/j.chembiol.2025.10.005_bib4","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1002\/ejp.1297","article-title":"European Pain Federation (EFIC) position paper on appropriate use of cannabis-based medicines and medical cannabis for chronic pain management","volume":"22","author":"Hauser","year":"2018","journal-title":"Eur. J. Pain"},{"key":"10.1016\/j.chembiol.2025.10.005_bib5","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1126\/science.abf6099","article-title":"Biological basis of cannabinoid medicines","volume":"374","author":"Keimpema","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.chembiol.2025.10.005_bib6","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.pain.2013.11.013","article-title":"Neuropathic pain in the general population: a systematic review of epidemiological studies","volume":"155","author":"van Hecke","year":"2014","journal-title":"Pain"},{"key":"10.1016\/j.chembiol.2025.10.005_bib7","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2017.2","article-title":"Neuropathic pain","volume":"3","author":"Colloca","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.chembiol.2025.10.005_bib8","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(14)70251-0","article-title":"Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis","volume":"14","author":"Finnerup","year":"2015","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.chembiol.2025.10.005_bib9","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1097\/j.pain.0000000000001929","article-title":"Cannabinoids, cannabis, and cannabis-based medicine for pain management: a systematic review of randomised controlled trials","volume":"162","author":"Fisher","year":"2021","journal-title":"Pain"},{"key":"10.1016\/j.chembiol.2025.10.005_bib10","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.7326\/M21-4520","article-title":"Cannabis-Based Products for Chronic Pain : A Systematic Review","volume":"175","author":"McDonagh","year":"2022","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.chembiol.2025.10.005_bib11","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.jpain.2023.10.009","article-title":"Cannabidiol (CBD) Products for Pain: Ineffective, Expensive, and With Potential Harms","volume":"25","author":"Moore","year":"2024","journal-title":"J. Pain"},{"key":"10.1016\/j.chembiol.2025.10.005_bib12","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.neubiorev.2017.02.006","article-title":"Neuronal and molecular effects of cannabidiol on the mesolimbic dopamine system: Implications for novel schizophrenia treatments","volume":"75","author":"Renard","year":"2017","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.chembiol.2025.10.005_bib13","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.neuron.2023.01.018","article-title":"Cannabidiol modulates excitatory-inhibitory ratio to counter hippocampal hyperactivity","volume":"111","author":"Rosenberg","year":"2023","journal-title":"Neuron"},{"key":"10.1016\/j.chembiol.2025.10.005_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2022.105670","article-title":"Synaptic changes induced by cannabinoid drugs and cannabis use disorder","volume":"167","author":"Augustin","year":"2022","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.chembiol.2025.10.005_bib15","doi-asserted-by":"crossref","first-page":"3613","DOI":"10.1038\/s41467-023-39307-6","article-title":"Cannabidiol inhibits Na(v) channels through two distinct binding sites","volume":"14","author":"Huang","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.chembiol.2025.10.005_bib16","doi-asserted-by":"crossref","first-page":"11229","DOI":"10.1073\/pnas.1711351114","article-title":"Cannabidiol attenuates seizures and social deficits in a mouse model of Dravet syndrome","volume":"114","author":"Kaplan","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.chembiol.2025.10.005_bib17","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1097\/j.pain.0000000000002268","article-title":"Cannabinoids, the endocannabinoid system, and pain: a review of preclinical studies","volume":"162","author":"Finn","year":"2021","journal-title":"Pain"},{"key":"10.1016\/j.chembiol.2025.10.005_bib18","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1097\/j.pain.0000000000002269","article-title":"Systematic review and meta-analysis of cannabinoids, cannabis-based medicines, and endocannabinoid system modulators tested for antinociceptive effects in animal models of injury-related or pathological persistent pain","volume":"162","author":"Soliman","year":"2021","journal-title":"Pain"},{"key":"10.1016\/j.chembiol.2025.10.005_bib19","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/bph.12439","article-title":"Cannabidiol inhibits paclitaxel-induced neuropathic pain through 5-HT(1A) receptors without diminishing nervous system function or chemotherapy efficacy","volume":"171","author":"Ward","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.chembiol.2025.10.005_bib20","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1111\/bph.15486","article-title":"Behavioural and pharmacological effects of cannabidiol (CBD) and the cannabidiol analogue KLS-13019 in mouse models of pain and reinforcement","volume":"178","author":"Foss","year":"2021","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.chembiol.2025.10.005_bib21","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.neuron.2012.02.008","article-title":"Deconstructing the neuropathic pain phenotype to reveal neural mechanisms","volume":"73","author":"von Hehn","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.chembiol.2025.10.005_bib22","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/s41586-018-0515-2","article-title":"Touch and tactile neuropathic pain sensitivity are set by corticospinal projections","volume":"561","author":"Liu","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.chembiol.2025.10.005_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2011.08.032","article-title":"Formulation design for poorly water-soluble drugs based on biopharmaceutics classification system: basic approaches and practical applications","volume":"420","author":"Kawabata","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.chembiol.2025.10.005_bib24","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/s40263-020-00741-5","article-title":"Critical Aspects Affecting Cannabidiol Oral Bioavailability and Metabolic Elimination, and Related Clinical Implications","volume":"34","author":"Perucca","year":"2020","journal-title":"CNS Drugs"},{"key":"10.1016\/j.chembiol.2025.10.005_bib25","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1007\/s00213-011-2415-0","volume":"219","author":"Deiana","year":"2012","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.chembiol.2025.10.005_bib26","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1016\/S0959-8049(01)00171-X","article-title":"Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation","volume":"37","author":"Gelderblom","year":"2001","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.chembiol.2025.10.005_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/molecules23102478","article-title":"Cannabinoid Delivery Systems for Pain and Inflammation Treatment","volume":"23","author":"Bruni","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.chembiol.2025.10.005_bib28","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41573-020-0090-8","article-title":"Engineering precision nanoparticles for drug delivery","volume":"20","author":"Mitchell","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.chembiol.2025.10.005_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119181","article-title":"Advantages of the combined use of cyclodextrins and nanocarriers in drug delivery: A review","volume":"579","author":"Mura","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.chembiol.2025.10.005_bib30","series-title":"Handbook of Pharmaceutical Excipients","author":"Rowe","year":"2009"},{"key":"10.1016\/j.chembiol.2025.10.005_bib31","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0304-3959(00)00276-1","article-title":"Spared nerve injury: an animal model of persistent peripheral neuropathic pain","volume":"87","author":"Decosterd","year":"2000","journal-title":"Pain"},{"key":"10.1016\/j.chembiol.2025.10.005_bib32","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.3389\/fphar.2018.01365","article-title":"A Systematic Review on the Pharmacokinetics of Cannabidiol in Humans","volume":"9","author":"Millar","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.chembiol.2025.10.005_bib33","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241914514","article-title":"Current Challenges and Opportunities for Improved Cannabidiol Solubility","volume":"24","author":"Hossain","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.chembiol.2025.10.005_bib34","doi-asserted-by":"crossref","DOI":"10.3390\/ph13090219","article-title":"Towards Better Delivery of Cannabidiol (CBD)","volume":"13","author":"Millar","year":"2020","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.chembiol.2025.10.005_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.121159","article-title":"Lipid-based formulations to increase cannabidiol bioavailability: In vitro digestion tests, pre-clinical assessment and clinical trial","volume":"609","author":"De Pra","year":"2021","journal-title":"Int J Pharm"},{"key":"10.1016\/j.chembiol.2025.10.005_bib36","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.3390\/nano10071403","article-title":"Polymeric Nanoparticles for Drug Delivery: Recent Developments and Future Prospects","volume":"10","author":"Begines","year":"2020","journal-title":"Nanomaterials"},{"key":"10.1016\/j.chembiol.2025.10.005_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2021.108712","article-title":"Cannabidiol effectively reverses mechanical and thermal allodynia, hyperalgesia, and anxious behaviors in a neuropathic pain model: Possible role of CB1 and TRPV1 receptors","volume":"197","author":"Silva-Cardoso","year":"2021","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.chembiol.2025.10.005_bib38","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/j.pain.0000000000001386","article-title":"Cannabidiol modulates serotonergic transmission and reverses both allodynia and anxiety-like behavior in a model of neuropathic pain","volume":"160","author":"De Gregorio","year":"2019","journal-title":"Pain"},{"key":"10.1016\/j.chembiol.2025.10.005_bib39","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1007\/s12325-018-0707-z","article-title":"Safety of Polysorbate 80 in the Oncology Setting","volume":"35","author":"Schwartzberg","year":"2018","journal-title":"Adv. Ther."},{"key":"10.1016\/j.chembiol.2025.10.005_bib40","doi-asserted-by":"crossref","DOI":"10.3390\/polym13030477","article-title":"Micellar Drug Delivery Systems Based on Natural Biopolymers","volume":"13","author":"Atanase","year":"2021","journal-title":"Polymers"},{"key":"10.1016\/j.chembiol.2025.10.005_bib41","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jconrel.2015.06.019","article-title":"Polymeric micelles and nanoemulsions as drug carriers: Therapeutic efficacy, toxicity, and drug resistance","volume":"212","author":"Gupta","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.chembiol.2025.10.005_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.122876","article-title":"Supersaturation maintenance of carvedilol and chlorthalidone by cyclodextrin derivatives: Pronounced crystallization inhibition ability of methylated cyclodextrin","volume":"637","author":"Liu","year":"2023","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.chembiol.2025.10.005_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.progpolymsci.2021.101408","article-title":"Cyclodextrin polymers: Structure, synthesis, and use as drug carriers","volume":"118","author":"Liu","year":"2021","journal-title":"Prog. Polym. Sci."},{"key":"10.1016\/j.chembiol.2025.10.005_bib44","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27092969","article-title":"Supersaturation-Based Drug Delivery Systems: Strategy for Bioavailability Enhancement of Poorly Water-Soluble Drugs","volume":"27","author":"Sharma","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.chembiol.2025.10.005_bib45","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1007\/s40265-021-01579-x","article-title":"Cannabinoid Formulations and Delivery Systems: Current and Future Options to Treat Pain","volume":"81","author":"Stella","year":"2021","journal-title":"Drugs"},{"key":"10.1016\/j.chembiol.2025.10.005_bib46","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1271\/bbb.62.2166","article-title":"Formation of Inclusion Complexes of Cyclodextrin with Ethanol under Anhydrous Conditions","volume":"62","author":"Yoshii","year":"1998","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"10.1016\/j.chembiol.2025.10.005_bib47","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/ddr.21452","article-title":"Cyclodextrin complexes: Perspective from drug delivery and formulation","volume":"79","author":"Jacob","year":"2018","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.chembiol.2025.10.005_bib48","doi-asserted-by":"crossref","first-page":"4700","DOI":"10.1039\/D1NJ05998J","article-title":"Cannabidiol\/hydroxypropyl-\u03b2-cyclodextrin inclusion complex: structure analysis, release behavior, permeability, and bioactivity under in vitro digestion","volume":"46","author":"Li","year":"2022","journal-title":"New J. Chem."},{"key":"10.1016\/j.chembiol.2025.10.005_bib49","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1159\/000526769","article-title":"Evaluations of Skin Permeability of Cannabidiol and Its Topical Formulations by Skin Membrane-Based Parallel Artificial Membrane Permeability Assay and Franz Cell Diffusion Assay","volume":"5","author":"Kirk","year":"2022","journal-title":"Med. Cannabis Cannabinoids"},{"key":"10.1016\/j.chembiol.2025.10.005_bib50","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/S1474-4422(15)00379-8","article-title":"Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial","volume":"15","author":"Devinsky","year":"2016","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.chembiol.2025.10.005_bib51","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1056\/NEJMoa1611618","article-title":"Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome","volume":"376","author":"Devinsky","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.chembiol.2025.10.005_bib52","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1056\/NEJMoa1714631","article-title":"Effect of Cannabidiol on Drop Seizures in the Lennox-Gastaut Syndrome","volume":"378","author":"Devinsky","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.chembiol.2025.10.005_bib53","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1093\/toxsci\/kfq207","article-title":"Comprehensive investigation of hydroxypropyl methylcellulose, propylene glycol, polysorbate 80, and hydroxypropyl-beta-cyclodextrin for use in general toxicology studies","volume":"117","author":"Thackaberry","year":"2010","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.chembiol.2025.10.005_bib54","series-title":"Hepatic Circulation: Physiology and Pathophysiology","author":"Lautt","year":"2010"},{"key":"10.1016\/j.chembiol.2025.10.005_bib55","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.3390\/molecules24091694","article-title":"Hepatotoxicity of a Cannabidiol-Rich Cannabis Extract in the Mouse Model","volume":"24","author":"Ewing","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.chembiol.2025.10.005_bib56","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1523\/JNEUROSCI.5609-07.2008","article-title":"Myelinated skin sensory neurons project extensively throughout adult mouse substantia gelatinosa","volume":"28","author":"Boada","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.chembiol.2025.10.005_bib57","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1152\/jn.00264.2007","article-title":"Physiological properties of mouse skin sensory neurons recorded intracellularly in vivo: temperature effects on somal membrane properties","volume":"98","author":"Boada","year":"2007","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.chembiol.2025.10.005_bib58","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.neuropharm.2017.11.036","article-title":"Pharmacological validation of voluntary gait and mechanical sensitivity assays associated with inflammatory and neuropathic pain in mice","volume":"130","author":"Shepherd","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.chembiol.2025.10.005_bib59","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1017\/S0265021507001226","article-title":"Gabapentin action and interaction on the antinociceptive effect of morphine on visceral pain in mice","volume":"25","author":"Meymandi","year":"2008","journal-title":"Eur. J. Anaesthesiol."},{"key":"10.1016\/j.chembiol.2025.10.005_bib60","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1046\/j.0003-2409.2001.02399.x","article-title":"Gabapentin: pharmacology and its use in pain management","volume":"57","author":"Rose","year":"2002","journal-title":"Anaesthesia"},{"key":"10.1016\/j.chembiol.2025.10.005_bib61","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.910719","article-title":"The association of gabapentin initiation and neurocognitive changes in older adults with normal cognition","volume":"13","author":"Oh","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.chembiol.2025.10.005_bib62","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.87414.3","article-title":"Adolescent neurostimulation of dopamine circuit reverses genetic deficits in frontal cortex function","volume":"12","author":"Mastwal","year":"2023","journal-title":"eLife"},{"key":"10.1016\/j.chembiol.2025.10.005_bib63","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1038\/sj.npp.1301384","article-title":"Effect of cannabinoid CB1 receptor antagonist SR141716A and CB1 receptor knockout on cue-induced reinstatement of Ensure and corn-oil seeking in mice","volume":"32","author":"Ward","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.chembiol.2025.10.005_bib64","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1016\/S0022-3565(24)36924-1","article-title":"SR141716A antagonizes the disruptive effects of cannabinoid ligands on learning in rats","volume":"282","author":"Brodkin","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.chembiol.2025.10.005_bib65","article-title":"Impact of genetic and pharmacological modulation of CB2 receptors on morphine-induced analgesia, tolerance, and reward in C57BL\/6J mice","author":"Omar","year":"2024","journal-title":"IBRO Neuroscience Reports"},{"key":"10.1016\/j.chembiol.2025.10.005_bib66","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.975020","article-title":"CB2 cannabinoid receptor expression is increased in 129S1\/SvImJ mice: behavioral consequences","volume":"13","author":"Ten-Blanco","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.chembiol.2025.10.005_bib67","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.neuron.2013.03.025","article-title":"Permanent genetic access to transiently active neurons via TRAP: targeted recombination in active populations","volume":"78","author":"Guenthner","year":"2013","journal-title":"Neuron"},{"key":"10.1016\/j.chembiol.2025.10.005_bib68","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/s41593-018-0318-7","article-title":"Temporal evolution of cortical ensembles promoting remote memory retrieval","volume":"22","author":"DeNardo","year":"2019","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.chembiol.2025.10.005_bib69","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/nrn2947","article-title":"Neuronal circuitry for pain processing in the dorsal horn","volume":"11","author":"Todd","year":"2010","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.chembiol.2025.10.005_bib70","article-title":"Modulation of itch and pain signals processing in ventrobasal thalamus by thalamic reticular nucleus","volume":"25","author":"Liu","year":"2022","journal-title":"iScience"},{"key":"10.1016\/j.chembiol.2025.10.005_bib71","article-title":"Reduced GABAergic transmission in the ventrobasal thalamus contributes to thermal hyperalgesia in chronic inflammatory pain","volume":"7","author":"Zhang","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.chembiol.2025.10.005_bib72","doi-asserted-by":"crossref","first-page":"R580","DOI":"10.1016\/j.cub.2017.05.010","article-title":"The insular cortex","volume":"27","author":"Gogolla","year":"2017","journal-title":"Curr. Biol."},{"key":"10.1016\/j.chembiol.2025.10.005_bib73","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1016\/j.pain.2014.07.009","article-title":"Differential structural and resting state connectivity between insular subdivisions and other pain-related brain regions","volume":"155","author":"Wiech","year":"2014","journal-title":"Pain"},{"key":"10.1016\/j.chembiol.2025.10.005_bib74","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24065736","article-title":"The Role of the Insular Cortex in Pain","volume":"24","author":"Labrakakis","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.chembiol.2025.10.005_bib75","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1007\/s12035-018-1130-9","article-title":"Role of the Prefrontal Cortex in Pain Processing","volume":"56","author":"Ong","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.chembiol.2025.10.005_bib76","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/j.celrep.2018.03.139","article-title":"Scaling Up Cortical Control Inhibits Pain","volume":"23","author":"Dale","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.chembiol.2025.10.005_bib77","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/nrn.2016.68","article-title":"Synaptic plasticity in the anterior cingulate cortex in acute and chronic pain","volume":"17","author":"Bliss","year":"2016","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.chembiol.2025.10.005_bib78","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0304-3959(03)00248-3","article-title":"Epileptiform activity in rat spinal dorsal horn in vitro has common features with neuropathic pain","volume":"105","author":"Ruscheweyh","year":"2003","journal-title":"Pain"},{"key":"10.1016\/j.chembiol.2025.10.005_bib79","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.neuron.2011.05.028","article-title":"Leptin action on GABAergic neurons prevents obesity and reduces inhibitory tone to POMC neurons","volume":"71","author":"Vong","year":"2011","journal-title":"Neuron"},{"key":"10.1016\/j.chembiol.2025.10.005_bib80","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.neuron.2015.02.022","article-title":"Transgenic mice for intersectional targeting of neural sensors and effectors with high specificity and performance","volume":"85","author":"Madisen","year":"2015","journal-title":"Neuron"},{"key":"10.1016\/j.chembiol.2025.10.005_bib81","doi-asserted-by":"crossref","first-page":"4153","DOI":"10.3390\/ijms23084153","article-title":"Crossing the Blood-Brain Barrier: Advances in Nanoparticle Technology for Drug Delivery in Neuro-Oncology","volume":"23","author":"Hersh","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.chembiol.2025.10.005_bib82","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1039\/C1CS15188F","article-title":"Toxicity of nanomaterials","volume":"41","author":"Sharifi","year":"2012","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.chembiol.2025.10.005_bib83","doi-asserted-by":"crossref","first-page":"673","DOI":"10.2217\/nnm.16.5","article-title":"The effect of nanoparticle size on in vivo pharmacokinetics and cellular interaction","volume":"11","author":"Hoshyar","year":"2016","journal-title":"Nanomedicine (Lond)"},{"key":"10.1016\/j.chembiol.2025.10.005_bib84","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/j.celrep.2015.09.080","article-title":"Dorsal Horn Parvalbumin Neurons Are Gate-Keepers of Touch-Evoked Pain after Nerve Injury","volume":"13","author":"Petitjean","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.chembiol.2025.10.005_bib85","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1038\/nn.4595","article-title":"Activation of cortical somatostatin interneurons prevents the development of neuropathic pain","volume":"20","author":"Cichon","year":"2017","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.chembiol.2025.10.005_bib86","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3389\/fncel.2018.00107","article-title":"Neuropathic Pain Causes Pyramidal Neuronal Hyperactivity in the Anterior Cingulate Cortex","volume":"12","author":"Zhao","year":"2018","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.chembiol.2025.10.005_bib87","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ejpain.2010.06.007","article-title":"Insular cortex lesion diminishes neuropathic and inflammatory pain-like behaviours","volume":"15","author":"Coffeen","year":"2011","journal-title":"Eur. J. Pain"},{"key":"10.1016\/j.chembiol.2025.10.005_bib88","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.2147\/JPR.S258433","article-title":"CBD Effects on TRPV1 Signaling Pathways in Cultured DRG Neurons","volume":"13","author":"Anand","year":"2020","journal-title":"J. Pain Res."},{"key":"10.1016\/j.chembiol.2025.10.005_bib89","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1084\/jem.20120242","article-title":"Cannabinoids suppress inflammatory and neuropathic pain by targeting alpha3 glycine receptors","volume":"209","author":"Xiong","year":"2012","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.chembiol.2025.10.005_bib90","doi-asserted-by":"crossref","first-page":"6371","DOI":"10.1523\/JNEUROSCI.3216-20.2021","article-title":"Cannabidiol Inhibition of Murine Primary Nociceptors: Tight Binding to Slow Inactivated States of Na(v)1.8 Channels","volume":"41","author":"Zhang","year":"2021","journal-title":"J. Neurosci."},{"key":"10.1016\/j.chembiol.2025.10.005_bib91","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.205","article-title":"Mechanisms of the gabapentinoids and alpha 2 delta-1 calcium channel subunit in neuropathic pain","volume":"4","author":"Patel","year":"2016","journal-title":"Pharmacol. Res. Perspect."},{"key":"10.1016\/j.chembiol.2025.10.005_bib92","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1038\/nm.3356","article-title":"Chloride extrusion enhancers as novel therapeutics for neurological diseases","volume":"19","author":"Gagnon","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.chembiol.2025.10.005_bib93","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1152\/physrev.00045.2019","article-title":"Neuropathic Pain: From Mechanisms to Treatment","volume":"101","author":"Finnerup","year":"2021","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.chembiol.2025.10.005_bib94","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/nn.3950","article-title":"Microcircuits and their interactions in epilepsy: is the focus out of focus?","volume":"18","author":"Paz","year":"2015","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.chembiol.2025.10.005_bib95","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.682","article-title":"Diversity of molecular targets and signaling pathways for CBD","volume":"8","author":"de Almeida","year":"2020","journal-title":"Pharmacol. Res. Perspect."},{"key":"10.1016\/j.chembiol.2025.10.005_bib96","doi-asserted-by":"crossref","first-page":"16546","DOI":"10.1074\/jbc.RA118.004929","article-title":"Inhibitory effects of cannabidiol on voltage-dependent sodium currents","volume":"293","author":"Ghovanloo","year":"2018","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.chembiol.2025.10.005_bib97","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1111\/bph.16035","article-title":"Differential regulation of Ca(v) 3.2 and Ca(v) 2.2 calcium channels by CB(1) receptors and cannabidiol","volume":"180","author":"Harding","year":"2023","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.chembiol.2025.10.005_bib98","doi-asserted-by":"crossref","first-page":"16124","DOI":"10.1074\/jbc.M707104200","article-title":"Inhibition of recombinant human T-type calcium channels by Delta9-tetrahydrocannabinol and cannabidiol","volume":"283","author":"Ross","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.chembiol.2025.10.005_bib99","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s12031-019-01321-z","article-title":"Knockdown siRNA Targeting the Mitochondrial Sodium-Calcium Exchanger-1 Inhibits the Protective Effects of Two Cannabinoids Against Acute Paclitaxel Toxicity","volume":"68","author":"Brenneman","year":"2019","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.chembiol.2025.10.005_bib100","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1523\/JNEUROSCI.4212-08.2009","article-title":"Cannabidiol targets mitochondria to regulate intracellular Ca2+ levels","volume":"29","author":"Ryan","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.chembiol.2025.10.005_bib101","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1152\/physrev.00002.2016","article-title":"From Phytocannabinoids to Cannabinoid Receptors and Endocannabinoids: Pleiotropic Physiological and Pathological Roles Through Complex Pharmacology","volume":"96","author":"Ligresti","year":"2016","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.chembiol.2025.10.005_bib102","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/s41386-019-0585-3","article-title":"Orally consumed cannabinoids provide long-lasting relief of allodynia in a mouse model of chronic neuropathic pain","volume":"45","author":"Abraham","year":"2020","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.chembiol.2025.10.005_bib103","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1001\/archinte.1972.03650040040005","article-title":"Micelle formation by bile salts. Physical-chemical and thermodynamic considerations","volume":"130","author":"Carey","year":"1972","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.chembiol.2025.10.005_bib104","series-title":"Encyclopedia of Pain","first-page":"1217","article-title":"Evoked and Movement-Related Neuropathic Pain","author":"Kehl","year":"2013"},{"key":"10.1016\/j.chembiol.2025.10.005_bib105","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1093\/bioinformatics\/btx180","article-title":"Trainable Weka Segmentation: a machine learning tool for microscopy pixel classification","volume":"33","author":"Arganda-Carreras","year":"2017","journal-title":"Bioinformatics"}],"container-title":["Cell Chemical Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451945625003423?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451945625003423?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T19:28:36Z","timestamp":1766172516000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2451945625003423"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":105,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S2451945625003423"],"URL":"https:\/\/doi.org\/10.1016\/j.chembiol.2025.10.005","relation":{},"ISSN":["2451-9456"],"issn-type":[{"value":"2451-9456","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rapid suppression of neuropathic pain and somatosensory hyperactivity by nano-formulated cannabidiol","name":"articletitle","label":"Article Title"},{"value":"Cell Chemical Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chembiol.2025.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}